Stockreport

Axovant Sciences: 5 Trials, 4 Failures - Expect A Fifth [Seeking Alpha]

Axon Enterprise, Inc.  (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.axovant.com/investors/sec-filings
PDF Axovant Sciences: 5 Trials, 4 Failures - Expect A FifthSummaryIntepirdine, Axovant's flagship drug, failed to meet primary endpoints in all three drug trials led by the [Read more]